Current empirical evidence suggests that HIV treatment does not completely eliminate the excess HPV-related disease progression and cervical cancer risk associated with HIV, and that it depends on CD4 at initiation and duration on ART.32 This evidence concerns the gene CD4 and cervical cancer.